NCT ID | NCT03361228 |
Title | A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | no |
Sponsors | Incyte Corporation |
Indications | |
Therapies | |
Age Groups: | adult senior |